TREATMENT-DEPENDENCE OF HIGH-RISK GENE EXPRESSION SIGNATURES IN DE NOVO FOLLICULAR LYMPHOMAS100 Bolen, C.; Hiddemann, W.; Marcus, R.; More Bolen, C.; Hiddemann, W.; Marcus, R.; Herold, M.; Huet, S.; Salles, G.; Mattiello, F.; Nielsen, T.; Mir, F.; Venstrom, J. M.; Oestergaard, M. Z. Less HemaSphere. 3:1, June 2019. Favorites PDF Get Content & Permissions Free
EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA: RESULTS OF THE PHASE III MABCUTE STUDYS101 Rule, S.; Barreto, Gois W.; Briones, J.; More Rule, S.; Barreto, Gois W.; Briones, J.; Carella, A. M.; Pocock, C.; Wendtner, C.-M.; Zaja, F.; Robson, S.; Tschopp, R. R.; Dreyling, M. Less HemaSphere. 3:1, June 2019. Favorites PDF Get Content & Permissions Free
POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) AND LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): INTERIM ANALYSIS OF A PHASE IB/II TRIALS102 Abrisqueta, P.; Kahl, B.; Banerjee, L.; More Abrisqueta, P.; Kahl, B.; Banerjee, L.; McMillan, A.; Ramchandren, R.; Miall, F.; Briones, J.; Cordoba, R.; Gonzalez-Barca, E.; Panizo, C.; Hirata, J.; Chang, N.; Musick, L.; Diefenbach, C. Less HemaSphere. 3:2-3, June 2019. Favorites PDF Get Content & Permissions Free
OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS, LYMA-101 TRIAL - A LYSA TRIALS103 Legouill, S.; Beldi-Ferchiou, A.; Cacheux, V.; More Legouill, S.; Beldi-Ferchiou, A.; Cacheux, V.; Alcantara, M.; Salles, G.; Canioni, D.; Bodet-Milin, C.; Delwail, V.; Gastinne, T.; thieblemont, C.; Moles, M.-P.; Damaj, G.; Jaccard, A.; Daguindau, N.; Ribrag, V.; Delfau-Larue, M.-H.; Macintyre, E.; Hermine, O. Less HemaSphere. 3:3, June 2019. Favorites PDF Get Content & Permissions Free
THE BRAF INHIBITOR VEMURAFENIB COMBINED WITH RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE REMISSIONS IN RELAPSED OR REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE-2 TRIALS104 Tiacci, E.; De Carolis, L.; Simonetti, E.; More Tiacci, E.; De Carolis, L.; Simonetti, E.; Zaja, F.; Capponi, M.; Ambrosetti, A.; Lucia, E.; Antolino, A.; Pulsoni, A.; Ferrari, S.; Zinzani, P. L.; Rigacci, L.; Gaidano, G.; Della Seta, R.; Frattarelli, N.; Falcucci, P.; Visani, G.; Foà , R.; Falini, B. Less HemaSphere. 3:3, June 2019. Favorites PDF Get Content & Permissions Free
GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE GCLLSG COMPARING FRONT LINE OBINUTUZUMAB PLUS CHLORAMBUCIL OR VENETOCLAX IN PATIENTS WITH COMORBIDITYS105 Tausch, E.; Bahlo, J.; Robrecht, S.; More Tausch, E.; Bahlo, J.; Robrecht, S.; Schneider, C.; Bloehdorn, J.; Schrell, S.; Galler, C.; Al-Sawaf, O.; Fink, A.-M.; Eichhorst, B.; Kreuzer, K.-A.; Tandon, M.; Humphrey, K.; Jiang, Y.; Schary, W.; Lurà , Porro M.; Döhner, H.; Fischer, K.; Hallek, M.; Stilgenbauer, S. Less HemaSphere. 3:4, June 2019. Favorites PDF Get Content & Permissions Free
HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIALS106 Al-Sawaf, O.; Lilienweiss, E.; Bahlo, J.; More Al-Sawaf, O.; Lilienweiss, E.; Bahlo, J.; Robrecht, S.; Fink, A.-M.; Patz, M.; Tandon, M.; Humphrey, K.; Jiang, Y.; Schary, W. L.; Lurà , Porro M.; Ritgen, M.; Tasch, E.; Stilgenbauer, S.; Eichhorst, B.; Fischer, K.; Hallek, M.; Kreuzer, K.-A. Less HemaSphere. 3:4-5, June 2019. Favorites PDF Get Content & Permissions Free
FIVE-YEAR FOLLOW-UP OF PATIENTS RECEIVING IBRUTINIB FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIAS107 Tedeschi, A.; Burger, J.; Barr, P. M.; More Tedeschi, A.; Burger, J.; Barr, P. M.; Robak, T.; Owen, C.; Ghia, P.; Bairey, O.; Hillmen, P.; Coutre, S.; Devereux, S.; Grosicki, S.; McCarthy, H.; Li, J.; Simpson, D.; Offner, F.; Moreno, C.; Dai, S.; Lal, I.; Dean, J. P.; Kipps, T. J. Less HemaSphere. 3:5-6, June 2019. Favorites PDF Get Content & Permissions Free
SAFETY ANALYSIS OF VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): SECOND INTERIM ANALYSIS FROM THE PHASE II VISION HO141 TRIALS108 Kater, A. P.; Dubois, J.; Kersting, S.; More Kater, A. P.; Dubois, J.; Kersting, S.; Enggaard, L.; Veldhuis, G. J.; Mous, R.; Mellink, C. H.; Dobber, J. A.; Poulsen, C. B.; Frederiksen, H.; Janssens, A.; Janssen, S. R.; Schjødt, I.; Dompeling, E. C.; Salmi, T.; Mattsson, M.; Bellido, M.; Tran, H. T.; Nasserinejad, K.; Levin, M.-D.; Niemann, C. U. Less HemaSphere. 3:6, June 2019. Favorites PDF Get Content & Permissions Free
TRANSCEND CLL 004: MINIMAL RESIDUAL DISEASE NEGATIVE RESPONSES AFTER LISOCABTAGENE MARALEUCEL (LISO-CEL) IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMAS109 Siddiqi, T.; Dorritie, K.; Soumerai, J.; More Siddiqi, T.; Dorritie, K.; Soumerai, J.; Stephens, D.; Dubovsky, J.; Gillenwater, H.; Gong, L.; Thorpe, J.; Yang, L.; Wierda, W. Less HemaSphere. 3:6-7, June 2019. Favorites PDF Get Content & Permissions Free
SCREENING OF CLUSTERED REGULATORY ELEMENTS REVEALS NOVEL LEUKEMIA DEPENDENCIESS110 Benbarche, S.; Lopez, C.; Salataj, E.; More Benbarche, S.; Lopez, C.; Salataj, E.; chaumeil, J.; Mercher, T.; Lobry, C. Less HemaSphere. 3:7, June 2019. Favorites PDF Get Content & Permissions Free
SIRT5 IS REQUIRED FOR ACUTE MYELOID LEUKEMIA GROWTH AND SURVIVAL AND MAY REPRESENT A NOVEL THERAPEUTIC TARGETS111 Yan, D.; Franzini, A.; Mason, C.; More Yan, D.; Franzini, A.; Mason, C.; Ahmann, J.; Heaton, W.; Clair, P.; Senina, A.; Halvorsen, B.; Than, H.; Khorashad, J.; Jones, C.; Pomicter, A.; O'Hare, T.; Deininger, M. Less HemaSphere. 3:8-8, June 2019. Favorites PDF Get Content & Permissions Free
MLL FUSIONS AFFECT SPLICING TO INDUCE EXPLOITABLE METABOLIC DEPENDENCIESS112 Garcia-Cuellar, M.-P.; Lawlor, J.; Böttcher, M.; More Garcia-Cuellar, M.-P.; Lawlor, J.; Böttcher, M.; Mougiakakos, D.; Slany, R. Less HemaSphere. 3:8, June 2019. Favorites PDF Get Content & Permissions Free
GENETICS AND MODELING OF HUMAN ACUTE ERYTHROID LEUKEMIAS113 Fagnan, A.; Piqué Borrà s, Riera M.; Ignacimouttou, C.; More Fagnan, A.; Piqué Borrà s, Riera M.; Ignacimouttou, C.; Bagger, Otzen F.; Lopez, C. K.; Caulier, A.; Aid, Z.; Thirant, C.; kurtovic, A.; Maciejewski, J.; Dierks, C.; Rambaldi, A.; Pabst, T.; Shimoda, K.; Lapillonne, H.; DeBotton, S.; Micoll, J.-B.; Caroll, M.; Valent, P.; Kile, B.; Carmichael, C.; Vyas, P.; Delabesse, E.; Gelsi-Boyer, V.; Birnbaum, D.; Anguita, E.; Garcon, L.; Soler, E.; Schwaller, J.; Mercher, T. Less HemaSphere. 3:8-9, June 2019. Favorites PDF Get Content & Permissions Free
POST-TRANSPLANT CYCLOPHOSPHAMIDE VS ATG FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN T-REPLETE HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT OF THE ALWP/EBMTS114 Nagler, A.; Labopin, M.; Ruggeri, A.; More Nagler, A.; Labopin, M.; Ruggeri, A.; Ciceri, F.; Sanz, J.; Angelucci, E.; Koc, Y.; Gülbas, Z.; Arcese, W.; Tischer, J.; Pioltelli, P.; Ozdogu, H.; Afanasyev, B.; Wu, D.; Arat, M.; Peric, Z.; Giebel, S.; Mohty, M. Less HemaSphere. 3:9, June 2019. Favorites PDF Get Content & Permissions Free
IMPACT OF MESURABLE RESIDUAL DISEASE POSITIVITY ON OUTCOMES FOLLOWING UNMBILICAL CORD BLOOD TRANSPLANTATION: A STUDY FROM THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT AND EUROCORDS115 Baron, F.; Labopin, M.; Ruggeri, A.; More Baron, F.; Labopin, M.; Ruggeri, A.; Sierra, J.; Robinson, S.; Labussière-Wallet, H.; Potter, M.; Santasusana, Ribera J. M.; Deconinck, E.; Rambaldi, A.; Rohrlich, P.-S.; de Revel, T.; Gluckman, E.; Nagler, A.; Mohty, M. Less HemaSphere. 3:9-10, June 2019. Favorites PDF Get Content & Permissions Free
A BUSULFAN FOLLOWING CYCLOPHOSPHAMIDE, PROTOCOL IMPROVED RESULTS IN ALTERNATIVE DONOR TRANSPLANT FOR PATIENTS WITH THALASSEMIA MAJOR: A RESULT FROM LONG-TERM LARGE-SIZE MULTI-CENTER STUDY IN CHINAS116 Li, C.; He, Y.; Jiang, H.; More Li, C.; He, Y.; Jiang, H.; Zhu, Y.; Wu, X.; Liu, S.; Liao, J.; Feng, X.; Liu, H.; Peng, Z.; Yang, X. Less HemaSphere. 3:10, June 2019. Favorites PDF Get Content & Permissions Free
THE ROLE OF ANTI-THYMOCYTE GLOBULIN WITH THIOTEPA-BUSULFAN-FLUDARABINE BASED CONDITIONING IN PATIENTS UNDERGOING HAPLOIDENTICAL STEM CELL TRANSPLANT AND POST-TRANSPLANT CYCLOPHOSPHAMIDES117 El-Cheikh, J.; Devillier, R.; Dulery, R.; More El-Cheikh, J.; Devillier, R.; Dulery, R.; Massoud, R.; Moukalled, N.; Ghaoui, N.; Pagliardini, T.; Marino, F.; Bazarbachi, A.; Castagna, L.; Mohty, M.; Blaise, D. Less HemaSphere. 3:10-11, June 2019. Favorites PDF Get Content & Permissions Free
IMPACT OF PRE-TRANSPLANT DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN CORD BLOOD TRANSPLANTATION ON BEHALF OF THE TRANSPLANT COMPLICATIONS WORKING GROUP OF JSHCTS118 Fuji, S.; Oshima, K.; Ohashi, K.; More Fuji, S.; Oshima, K.; Ohashi, K.; Sawa, M.; Saito, K.; Eto, T.; Tanaka, M.; Onizuka, M.; Nakamae, H.; Shiratori, S.; Ozawa, Y.; Hidaka, M.; Nagamura-Inoue, T.; Tanaka, H.; Fukuda, T.; Ichinohe, T.; Atsuta, Y.; Ogata, M. Less HemaSphere. 3:11, June 2019. Favorites PDF Get Content & Permissions Free
THE ROLE OF RECURRENT SOMATIC ALTERATIONS IN THE NON-CODING GENOME WITH FUNCTIONAL IMPLICATIONS IN MMS119 Samur, M.; Szalat, R.; Samur, Aktas A.; More Samur, M.; Szalat, R.; Samur, Aktas A.; Fulciniti, M.; Lopez, M.; Shammas, M.; Richardson, P.; Magrangeas, F.; Minvielle, S.; Moreau, P.; Attal, M.; Thakurta, A.; Anderson, K.; Parmigiani, G.; Avet-Loiseau, H.; Munshi, N. Less HemaSphere. 3:11-12, June 2019. Favorites PDF Get Content & Permissions Free
CHRONOLOGY OF COPY NUMBER ALTERATIONS FROM PRECURSORS TO MULTIPLE MYELOMA: WHAT COMES FIRST?S120 Samur, Aktas A.; Minvielle, S.; Fulciniti, M.; More Samur, Aktas A.; Minvielle, S.; Fulciniti, M.; Szalat, R.; Shammas, M.; Magrangeas, F.; Moreau, P.; Attal, M.; Anderson, K.; Parmigiani, G.; Avet-Loiseau, H.; Munshi, N.; Samur, M. Less HemaSphere. 3:12, June 2019. Favorites PDF Get Content & Permissions Free
SINGLE-CELL CHARACTERIZATION OF THE MULTIPLE MYELOMA (MM) IMMUNE MICROENVIRONMENT IDENTIFIES CD27- T CELLS AS POTENTIAL SOURCE OF TUMOR-REACTIVE LYMPHOCYTESS121 Botta, C.; Perez, C.; Puig, N.; More Botta, C.; Perez, C.; Puig, N.; Cedena, M. T.; Cordon, L.; Zabaleta, A.; Burgos, L.; Maia, C.; Goicoechea, I.; Rodriguez, S.; Rodriguez, I.; Sarvide, S.; Alignani, D.; Vilas-Zornoza, A.; Lorenzo-Vivas, E.; Rosiñol, L.; Oriol, A.; Blanchard, M.-J.; Rios, R.; Sureda, A.; Martinez, R.; Martin, J.; Bargay, J.; de la Rubia, J.; Rossi, M.; Tagliaferri, P.; Tassone, P.; Merino, J.; Prosper, F.; Orfao, A.; Mateos, M.-V.; Lahuerta, J.-J.; Bladé, J.; San Miguel, J.; Paiva, B. Less HemaSphere. 3:12-13, June 2019. Favorites PDF Get Content & Permissions Free
THE FIRST-IN-CLASS, ORALLY AVAILABLE BMI-1 MODULATORS PTC-028 AND PTC596 DISPLAY POTENT ACTIVITY IN PRE-CLINICAL MODELS OF MULTIPLE MYELOMAS122 Bolomsky, A.; Muller, J.; Stangelberger, K.; More Bolomsky, A.; Muller, J.; Stangelberger, K.; Lejeune, M.; Arnold, D.; Duray, E.; Breid, H.; Vrancken, L.; Hübl, W.; Willheim, M.; Weetall, M.; Branstrom, A.; Zojer, N.; Caers, J.; Ludwig, H. Less HemaSphere. 3:13, June 2019. Favorites PDF Get Content & Permissions Free
SETD2 LOSS OF FUNCTION IS A RECURRENT EVENT IN ADVANCED-PHASE CHRONIC MYELOID LEUKEMIA INDUCED BY POST-TRANSLATIONAL MECHANISMS THAT CAN BE THERAPEUTICALLY TARGETEDS123 Mancini, M.; De Santis, S.; Monaldi, C.; More Mancini, M.; De Santis, S.; Monaldi, C.; Bavaro, L.; Martelli, M.; Castagnetti, F.; Gugliotta, G.; Rosti, G.; Fontana, M. C.; Dan, E.; Sinigallia, B.; Iurlo, A.; Orofino, N.; Abbruzzese, E.; Salvucci, M.; Pregno, P.; Gozzini, A.; Crugnola, M.; Albano, F.; Bonifacio, M.; Calistri, E.; Tiribelli, M.; Binotto, G.; Imovilli, A.; Trabacchi, E.; Galimberti, S.; Baratè, C.; Tenti, E.; Baccarani, M.; Martinelli, G.; Cavo, M.; Soverini, S. Less HemaSphere. 3:13-14, June 2019. Favorites PDF Get Content & Permissions Free
IDENTIFICATION OF THE DOPAMINE AND SEROTONIN TRANSPORTERS SLC6A3 AND SLC6A4 AS NOVEL SURVIVAL FACTORS IN LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKAEMIAS124 Aldosari, A.; Ritchie, J.; Calvo-Sánchez, J.; More Aldosari, A.; Ritchie, J.; Calvo-Sánchez, J.; Hewit, K.; James, D.; Dunn, K.; Copland, M.; Holyoake, T.; Shanks, E.; Scott, M.; Vetrie, D. Less HemaSphere. 3:14, June 2019. Favorites PDF Get Content & Permissions Free
PATHWAY AND GENE SET OVERDISPERSION ANALYSIS OF SINGLE CELL TRANSCRIPTOMIC DATA FROM PATIENTS WITH CHRONIC MYELOID LEUKAEMIA HIGHLIGHTS TRANSCRIPTIONAL HETEROGENEITY IN CD34+CD38- CELLSS125 Dunn, W.; Hopcroft, L. Dunn, W.; Hopcroft, L. Less HemaSphere. 3:14-15, June 2019. Favorites PDF Get Content & Permissions Free
COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS.S126 Munje, C.; Hyde, R.; Kinstrie, R.; More Munje, C.; Hyde, R.; Kinstrie, R.; Mitchell, R.; Scott, M.; Helgason, V.; Jorgensen, H.; Vetrie, D.; Copland, M. Less HemaSphere. 3:15, June 2019. Favorites PDF Get Content & Permissions Free
CHRONIC MYELOID LEUKEMIA IS ASSOCIATED WITH INCREASED NEUTROPHIL EXTRACELLULAR TRAP FORMATION THAT IS AUGMENTED BY PONATINIB - A POTENTIAL CONTRIBUTOR TO VASCULAR TOXICITY?S127 Telerman, A.; Granot, G.; Shacham-Abulafia, A.; More Telerman, A.; Granot, G.; Shacham-Abulafia, A.; Ellis, M. H.; Yarchovsky-Dolberg, O.; Raanani, P.; Wolach, O. Less HemaSphere. 3:15-16, June 2019. Favorites PDF Get Content & Permissions Free
BCP- AND T-ALL CELLS HIDE IN DISTINCT NICHES OF THE BONE MARROWS128 Capron, D.; Zuchtriegel, G.; Behrmann, L.; More Capron, D.; Zuchtriegel, G.; Behrmann, L.; Kunz, L.; Marovca, B.; Kirschmann, M.; Nombela-Arrieta, C.; Suessbier, U.; Ziegler, U.; Schroeder, T.; Bornhauser, B.; Bourquin, J.-P. Less HemaSphere. 3:16, June 2019. Favorites PDF Get Content & Permissions Free
TP53 SOMATIC MUTATIONS AS PRE-LEUKEMIC EVENTS IN ACUTE LYMPHOBLASTIC LEUKEMIAS129 Chitadze, G.; Stengel, A.; John-Klaua, C.; More Chitadze, G.; Stengel, A.; John-Klaua, C.; Trautmann, H.; knecht, H.; Schwarz, M.; Kotrova, M.; Hollmann, J.; Hermann, D.; Appelt, F.; Theocharis, T.; Pal, K.; Darzentas, N.; Oberg, H.-H.; Kabelitz, D.; Gökbuget, N.; Baldus, C.; Haferlach, C.; Brüggemann, M. Less HemaSphere. 3:16-17, June 2019. Favorites PDF Get Content & Permissions Free
TRANSIENT SUBCLONES CARRYING NT5C2 MUTATIONS DEFINE A HIGH-RISK PATIENT GROUP WITH POOR OUTCOME IN PEDIATRIC RELAPSED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIAS130 Pogodzinski, M. J.; Hof, J.; Groeneveld-Krentz, S.; More Pogodzinski, M. J.; Hof, J.; Groeneveld-Krentz, S.; Szymansky, A.; von Stackelberg, A.; Ferrando, A. A.; Eckert, C.; Kirschner-Schwabe, R. Less HemaSphere. 3:17, June 2019. Favorites PDF Get Content & Permissions Free
IL7R EXPRESSION PREDICTS T-ALL SENSITIVITY TO JAK INHIBITORS REGARDLESS OF IL7R/JAK/STAT MUTATIONAL STATUSS131 Kim, R.; Tueur, G.; Delecourt, M.; More Kim, R.; Tueur, G.; Delecourt, M.; Boissel, N.; Feroul, M.; Latiri, M.; Vilarese, P.; Hippolyte, G.; Tesio, M.; Andrieu, G.; Ifrah, N.; Petit, A.; Dombret, H.; Macintyre, E.; Asnafi, V.; Lhermitte, L. Less HemaSphere. 3:17-18, June 2019. Favorites PDF Get Content & Permissions Free
BIOLOGICAL CHARACTERIZATION OF THE U2AF1 S34F MUTATION IN THE PATHOGENESIS OF MYELODYSPLASIAS132 Kon, A.; Nannya, Y.; Kataoka, K.; More Kon, A.; Nannya, Y.; Kataoka, K.; Nakayama, M.; Koseki, H.; Sanada, M.; Makishima, H.; Nakagawa, M. M.; Ogawa, S. Less HemaSphere. 3:19, June 2019. Favorites PDF Get Content & Permissions Free
EX VIVO DRUG SENSITIVITY PROFILING IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS DEFINES NOVEL DRUG SENSITIVITY PATTERNS FOR PREDICTING CLINICAL THERAPEUTIC OUTCOMESS133 Aleshin, A.; Santaguida, M. T.; Schaffert, S. A.; More Aleshin, A.; Santaguida, M. T.; Schaffert, S. A.; Spinner, M. A.; Sanders, J. N.; Zehnder, J.; Patterson, A. S.; Heiser, D.; Greenberg, P. L. Less HemaSphere. 3:19, June 2019. Favorites PDF Get Content & Permissions Free
CLONAL HEMATOPOIESIS IN ELDERLY TWINS: CONCORDANCE, DISCORDANCE AND SURVIVALS134 Hansen, J. W.; Pedersen, D. A.; Larsen, L. A.; More Hansen, J. W.; Pedersen, D. A.; Larsen, L. A.; Husby, S.; Favero, F.; Weischenfeldt, J.; Christensen, K.; Grønbæk, K. Less HemaSphere. 3:19, June 2019. Favorites PDF Get Content & Permissions Free
NGS-BASED COPY-NUMBER ANALYSIS IN MORE THAN 2,000 PATIENTS WITH MYELOID NEOPLASMSS135 Saiki, R.; Shiozawa, Y.; Yoshizato, T.; More Saiki, R.; Shiozawa, Y.; Yoshizato, T.; Nanya, Y.; Takeda, J.; Yoshida, K.; Shiraishi, Y.; Tanaka, H.; Chiba, K.; Atsuta, Y.; Onizuka, M.; Itonaga, H.; Sanada, M.; Kanda, Y.; Przychodzen, B.; Sekeres, M. A.; Guinta, K. M.; Saunthararajah, Y.; Shih, L.-Y.; Miyawaki, S.; Nakamaki, T.; Taguchi, M.; Fuji, S.; Sasaki, N.; Uoshima, N.; Ueda, Y.; Miyazaki, Y.; Usuki, K.; Imada, K.; Takaori-Kondo, A.; Chiba, S.; Kasahara, S.; Kiguchi, T.; Tsurumi, H.; Malcovati, L.; Cazzola, M.; Ishikawa, T.; Miyano, S.; Maciejewski, J. P.; Makishima, H.; Ogawa, S. Less HemaSphere. 3:19-20, June 2019. Favorites PDF Get Content & Permissions Free
REPROGRAMMING HEMATOPOIETIC STEM CELL FUNCTION VIA MODULATION OF MITOCHONDRIAL ACTIVITYS136 Girotra, M.; Rincon-Restrepo, M.; Oggier, A.; More Girotra, M.; Rincon-Restrepo, M.; Oggier, A.; Coukos, G.; Naveiras, O.; Rezzi, S.; Vannini, N. Less HemaSphere. 3:20, June 2019. Favorites PDF Get Content & Permissions Free
DNA METHYLATION DYNAMICS IDENTIFY LINEAGE-SPECIFIC REGULATION PATTERNS OF HEMATOPOIETIC DIFFERENTIATIONS137 Stäble, S.; Krämer, S.; Langstein, J.; More Stäble, S.; Krämer, S.; Langstein, J.; Bogeska, R.; Hartmann, M.; Schönung, M.; Anstee, N.; Haas, S.; Weichenhan, D.; Czeh, M.; Gräsel, J.; Hübschmann, D.; Rosenbauer, F.; Plass, C.; Schlesner, M.; Milsom, M.; Lipka, D. Less HemaSphere. 3:20, June 2019. Favorites PDF Get Content & Permissions Free
A DISTINCT WAVE OF HSC-DERIVED T CELL-ILC-RESTRICTED PROGENITORS INITIATES THE EMBRYONIC THYMUSS138 Elsaid, R.; Yang, J.; Iturri, L.; More Elsaid, R.; Yang, J.; Iturri, L.; Rodewald, H.-R.; Perdiguero, E. G.; Cumano, A. Less HemaSphere. 3:20-21, June 2019. Favorites PDF Get Content & Permissions Free
JUNCTIONAL ADHESION MOLECULE A (JAM-A) IS A CRITICAL REGULATOR OF HSC HOMING AND MAINTENANCE OF STEM CELL QUIESCENCES139 Cao, B.; Hart, C.; Iberl, S.; More Cao, B.; Hart, C.; Iberl, S.; Müller, G.; Williams, B.; Heazlewood, S.; Domingues, M.; Vinson, A.; Sun, X.; Li, S.; Heazlewood, C.; Pritchard, C.; Haylock, D.; Nefzger, C.; Polo, J.; Schelker, R.; Herr, W.; Martin-Padura, I.; Grassinger, J.; Nilsson, S. Less HemaSphere. 3:21, June 2019. Favorites PDF Get Content & Permissions Free
RESULTS FROM THE PHASE 3 NORTHSTAR-3 STUDY EVALUATING LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSAEMIA AND A β0 OR IVS-I-110 MUTATION AT BOTH ALLELES OF THE HBB GENES140 Kulozik, A. E.; Locatelli, F.; Yannaki, E.; More Kulozik, A. E.; Locatelli, F.; Yannaki, E.; Porter, J. B.; Thuret, I.; Sauer, M. G.; Lal, A.; Kwiatkowski, J. L.; Elliot, H.; Tao, G.; Colvin, R. A.; Thompson, A. A. Less HemaSphere. 3:21-22, June 2019. Favorites PDF Get Content & Permissions Free
CLINICAL OUTCOMES OF LENTIGLOBIN GENE THERAPY FOR TRANSFUSION-DEPENDENT β-THALASSAEMIA (TDT) FOLLOWING COMPLETION OF THE NORTHSTAR (HGB-204) STUDYS141 Walters, M. C.; Kwiatkowski, J. L.; Rasko, J. E.J.; More Walters, M. C.; Kwiatkowski, J. L.; Rasko, J. E.J.; Hongeng, S.; Schiller, G. J.; Anurathapan, U.; Cavazzana, M.; Ho, P. J.; Schmidt, M.; Kletzel, M.; Leboulch, P.; Vichinsky, E.; Deary, B.; Chen, Y.; Petrusich, A.; Thompson, A. A. Less HemaSphere. 3:22, June 2019. Favorites PDF Get Content & Permissions Free
FIRST-IN-CLASS ORAL FERROPORTIN INHIBITOR: MODE OF ACTION AND EFFICACY IN A MOUSE MODEL OF BETA-THALASSEMIA INTERMEDIAS142 Manolova, V.; Nyffenegger, N.; Flace, A.; More Manolova, V.; Nyffenegger, N.; Flace, A.; Altermatt, P.; Doucerain, C.; Sundström, H.; Dürrenberger, F. Less HemaSphere. 3:22-23, June 2019. Favorites PDF Get Content & Permissions Free
LUSPATERCEPT INCREASES FETAL HEMOGLOBIN (HBF) LEVELS IN ADULT β-THALASSEMIA PATIENTS WHO REQUIRE RED BLOOD CELL (RBC) TRANSFUSIONSS143 Cappellini, M.-D.; Schwickart, M.; Hermine, O.; More Cappellini, M.-D.; Schwickart, M.; Hermine, O.; Piga, A.; Risueño, A.; Acar, M.; Zinger, T.; Laadem, A.; Shetty, J.; Morison, J.; Miteva, D.; MacBeth, K.; Taher, A. Less HemaSphere. 3:23, June 2019. Favorites PDF Get Content & Permissions Free
A MULTICENTRE, RANDOMIZED, NON-INFERIORITY TRIAL COMPARING THE EFFICACY OF DEFERIPRONE VERSUS DEFERASIROX IN PEDIATRIC PATIENTS AFFECTED BY TRANSFUSION-DEPENDENT HEMOGLOBINOPATHIES (DEEP-2 TRIAL)S144 Kattamis, A.; Felisi, M.; Reggiardo, G.; More Kattamis, A.; Felisi, M.; Reggiardo, G.; El-Beshlawy, A.; Bejaoui, M.; Sherief, L.; Christou, S.; Cosmi, C.; Della Pasqua, O.; Del Vecchio, G. C.; Filosa, A.; Hassab, H.; Kreka, M.; Origa, R.; Putti, M. C.; Spino, M.; Telfer, P.; Tempesta, B.; Tsang, Y. C.; Zaka, A.; Tricta, F.; Bonifazi, D.; Ceci, A.; Maggio, A. Less HemaSphere. 3:23-24, June 2019. Favorites PDF Get Content & Permissions Free
PHASE 3 RANDOMIZED STUDY OF DARATUMUMAB + BORTEZOMIB/THALIDOMIDE/DEXAMETHASONE (D-VTD) VERSUS VTD IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: PART 1 CASSIOPEIA RESULTSS145 Moreau, P.; Attal, M.; Hulin, C.; More Moreau, P.; Attal, M.; Hulin, C.; Arnulf, B.; Belhadj, K.; Benboubker, L.; Béné, M. C.; Broijl, A.; Caillon, H.; Caillot, D.; Corre, J.; Delforge, M.; Dejoie, T.; Doyen, C.; Facon, T.; Sonntag, C.; Garderet, L.; Jie, K.-S.; Karlin, L.; Kuhnowski, F.; Lambert, J.; Leleu, X.; Lenain, P.; Macro, M.; Orsini-Piocelle, F.; Perrot, A.; Stoppa, A.-M.; van de Donk, N. W.; Wuilleme, S.; Zweegman, S.; Kolb, B.; Touzeau, C.; Roussel, M.; Tiab, M.; Marolleau, J.-P.; Meuleman, N.; Vekemans, M.-C.; Westerman, M.; Klein, S. K.; Levin, M.-D.; Escoffre-Barbe, M.; Eveillard, J.-R.; Garidi, R.; Ahmadi, T.; Zhuang, S.; Chiu, C.; Pei, L.; Vanquickelberghe, V.; de Boer, C.; Smith, E.; Deraedt, W.; Kampfenkel, T.; Schecter, J.; Vermeulen, J.; Avet-Loiseau, H.; Sonneveld, P. Less HemaSphere. 3:24-25, June 2019. Favorites PDF Get Content & Permissions Free
DECIPHERING THE ROLE OF RUNX1 ISOFORMS IN THE DEVELOPMENT OF TRANSIENT ABNORMAL MYELOPOIESISS146 Gialesaki, S.; Labuhn, M.; Bräuer-Hartmann, D.; More Gialesaki, S.; Labuhn, M.; Bräuer-Hartmann, D.; Matzk, S.; Strüwe, F.-J.; Kadel, S.-K.; Schmid, L.; Amstislavskiy, V.; Risch, T.; Yaspo, M.-L.; Heckl, D.; Klusmann, J.-H. Less HemaSphere. 3:25, June 2019. Favorites PDF Get Content & Permissions Free
RESULTS FROM THE RANDOMIZED PLACEBO-CONTROLLED PHASE 3 HOPE TRIAL OF VOXELOTOR IN ADULTS AND ADOLESCENTS WITH SICKLE CELL DISEASES147 Vichinsky, E.; Hoppe, C. C.; Ataga, K. I.; More Vichinsky, E.; Hoppe, C. C.; Ataga, K. I.; Ware, R. E.; Nduba, V.; El Beshlawy, A.; Hassab, H.; Achebe, M. M.; Al-Kindi, S.; Brown, C.; Diuguid, D. L.; Telfer, P.; Tsitsikas, D. A.; El Ghandour, A.; Gordeuk, V. R.; Kanter, J.; Abboud, M. R.; Lehrer-Graiwer, J.; Tonda, M.; Intondi, A.; Tong, B.; Howard, J. Less HemaSphere. 3:25-26, June 2019. Favorites PDF Get Content & Permissions Free
TFR2-HAPLOINSUFFICIENCY ENHANCES THE BENEFICIAL EFFECT OF TMPRSS6-ANTISENSE OLIGONUCLEOTIDE TREATMENT IN BETA-THALASSEMIA MICES148 Pettinato, M.; Aghajan, M.; Lidonnici, M. R.; More Pettinato, M.; Aghajan, M.; Lidonnici, M. R.; Olivari, V.; Silvestri, L.; Guo, S.; Ferrari, G.; Camaschella, C.; Nai, A. Less HemaSphere. 3:26, June 2019. Favorites PDF Get Content & Permissions Free
FIXED-DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PROGRESSION-FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIESS149 Fischer, K.; Al-Sawaf, O.; Bahlo, J.; More Fischer, K.; Al-Sawaf, O.; Bahlo, J.; Fink, A.-M.; Tandon, M.; Dixon, M.; Robrecht, S.; Warburton, S.; Humphrey, K.; Samoylova, O.; Liberati, A. M.; Pinilla-Ibarz, J.; Opat, S.; Sivcheva, L.; Le Dû, K.; Fogliatto, Maria L.; Niemann, Utoft C.; Weinkove, R.; Robinson, S.; Kipps, T. J.; Boettcher, S.; Tausch, E.; Schary, W. L.; Eichhorst, B.; Wendtner, C.-M.; Langerak, A. W.; Kreuzer, K.-A.; Goede, V.; Stilgenbauer, S.; Mobasher, M.; Ritgen, M.; Hallek, M. Less HemaSphere. 3:26-27, June 2019. Favorites PDF Get Content & Permissions Free
ADAM28 OVEREXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA PROMOTE ITS INVASION IN CENTRAL NEURAL SYSTEM VIA CROSS TALKING WITH CXCR4 PATHWAYPF150 Wang, C.; Wang, Y.; Zhang, G.; More Wang, C.; Wang, Y.; Zhang, G.; Su, Y.; Liu, X.; Zhang, J.; Zhang, Y.; Fu, H.; Zhao, X.; Chang, Y.; Liu, K.; Huang, X.; Zhang, X. Less HemaSphere. 3:27-28, June 2019. Favorites PDF Get Content & Permissions Free
RAS/MAPK ACTIVATION COOPERATES WITH GAIN OF CHROMOSOME 21 IN B CELL LEUKEMIA AND IS AN ATTRACTIVE TARGET TO IMPROVE THE OUTCOME OF DS CHILDREN WITH B-ALLPF151 Laurent, A. P.; Siret, A.; Ignacimouttou, C.; More Laurent, A. P.; Siret, A.; Ignacimouttou, C.; Diop, M.; Tsai, Y.-C.; Roos-Weil, D.; Plassard, D.; Lagarde, S.; Prade, N.; Aid, H.; Meurice, G.; Bernard, O.; Bonnigal, Barin C.; MacIntyre, E.; Cheung, L.; Kotecha, R.; Bornhauser, B.; Bourquin, J.-P.; Ballerini, P.; Delabesse, E.; Mercher, T.; Malinge, S. Less HemaSphere. 3:28, June 2019. Favorites PDF Get Content & Permissions Free
XBP1 PROMOTES PRE-B CELL ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH OF IL-7 RECEPTOR SIGNALING IN MICEPF152 Salimi, A.; Vieri, M.; Schemionek, M.; More Salimi, A.; Vieri, M.; Schemionek, M.; Huber, M.; Brümmendorf, T. H.; Masouleh, Kharabi B.; Appelmann, I. Less HemaSphere. 3:29, June 2019. Favorites PDF Get Content & Permissions Free
MLL-AF4 CAUSES ABERRANT UPREGULATION OF PROM1 (CD133) IN ACUTE LYMPHOBLASTIC LEUKEMIA BY CONTROLLING ENHANCER-PROMOTER INTERACTIONSPF153 Godfrey, L.; O'Byrne, S.; Crump, N. T.; More Godfrey, L.; O'Byrne, S.; Crump, N. T.; Lau, I.-J.; Thorne, R.; Elliott, N.; Buck, G.; Rice, S.; Connor, C.; Thomas, R.; Cheng, D.; Ancliff, P.; Inglott, S.; Roberts, I.; Roy, A.; Milne, T. A. Less HemaSphere. 3:29, June 2019. Favorites PDF Get Content & Permissions Free
®PF155 Lukic, Slavkovic D.; Duell, J.; Davidson-Moncada, J.; More Lukic, Slavkovic D.; Duell, J.; Davidson-Moncada, J.; Schlagowsky, A.; Einsele, H.; Szczepanowski, M.; Schewe, D. M.; Brüggemann, M.; Topp, M. S. Less HemaSphere. 3:29-30, June 2019. Favorites PDF Get Content & Permissions Free
SINGLE-CELL TRANSCRIPTIONAL HETEROGENEITY SUGGESTS NOVEL FINGERPRINT OF RELAPSE IN ACUTE MYELOID LEUKEMIAPF156 Wang, Z.; Wang, R.; Yang, C.; More Wang, Z.; Wang, R.; Yang, C.; liu, Y.; Zhang, C.; Gao, L.; Zhang, X. Less HemaSphere. 3:30, June 2019. Favorites PDF Get Content & Permissions Free
THERAPEUTIC TARGETING OF CYTOKINE INDUCED PIM1 ACTIVATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMAPF157 De Smedt, R.; Peirs, S.; Van Trimpont, M.; More De Smedt, R.; Peirs, S.; Van Trimpont, M.; Morscio, J.; Roels, J.; Reunes, L.; Lintermans, B.; Lammens, T.; Van Roy, N.; De Moerloose, B.; Benoit, Y.; Meijerink, J. P.; Goossens, S.; Van Vlierberghe, P. Less HemaSphere. 3:30, June 2019. Favorites PDF Get Content & Permissions Free
TARGETING ONCOGENIC NOTCH1 IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH A NEW SELECTIVE SERCA INHIBITOR CAD204520PF158 Marchesini, M.; Gherli, A.; Winter, A.-M. Lund; More Marchesini, M.; Gherli, A.; Winter, A.-M. Lund; Patrizi, L.; Kitara, S.; Montanaro, A.; Rompietti, C.; Sorrentino, C.; Stilli, D.; Rizzi, F.; Loiacono, C.; Pagliaro, L.; La Starza, R.; Mecucci, C.; Aversa, F.; Sportoletti, P.; Dalby-Brown, W.; Roti, G. Less HemaSphere. 3:31, June 2019. Favorites PDF Get Content & Permissions Free
COMBINATION OF SELECTIVE GAMMA-SECRETASE INHIBITOR MRK-560 WITH OTHER TARGETED THERAPY IS AN EFFECTIVE AND SAFE TREATMENT FOR T-ALLPF159 Govaerts, I.; Gielen, O.; Habets, R.; More Govaerts, I.; Gielen, O.; Habets, R.; de Bock, C.; De Keersmaecker, K.; Segers, H.; Uyttebroeck, A.; Maertens, J.; Boeckx, N.; De Strooper, B.; Cools, J. Less HemaSphere. 3:31, June 2019. Favorites PDF Get Content & Permissions Free
IKZF1 DELETIONS DO NOT HAVE A STRONG IMPACT ON EVENT FREE SURVIVAL IN PATIENTS WITH B-PRECURSOR ALL TREATED ON THE UKALL14 TRIAL (ISRCTN 66541317)PF160 Mitchell, R. J.; Kirkwood, A. A.; Barretta, E.; More Mitchell, R. J.; Kirkwood, A. A.; Barretta, E.; Hadley, Clifton L.; Lawrie, E.; Marks, D. I.; McMillan, A. K.; Tobias, M.; Patrick, P.; Rowntree, C. J.; Wrench, B.; Moorman, A. V.; Fielding, A. K. Less HemaSphere. 3:31-32, June 2019. Favorites PDF Get Content & Permissions Free
THIOREDOXIN SYSTEM INHIBITORS ARE EFFECTIVE AGAINST B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VITRO AND IN VIVOPF161 Fidyt, K.; Pastorczak, A.; Goral, A.; More Fidyt, K.; Pastorczak, A.; Goral, A.; Muchowicz, A.; Komorowski, L.; Cyran, J.; Pal, D.; Blair, H.; Burdzinska, A.; Pedzisz, P.; Patkowska, E.; Lech-Maranda, E.; Mlynarski, W.; Golab, J.; Firczuk, M. Less HemaSphere. 3:32-33, June 2019. Favorites PDF Get Content & Permissions Free
FREQUENCY AND PROGNOSTIC IMPACT OF ZEB2 H1038/Q1072 MUTATIONS IN CHILDHOOD B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIAPF162 Zaliova, M.; Potuckova, E.; Lukes, J. Jr.; More Zaliova, M.; Potuckova, E.; Lukes, J. Jr.; Winkowska, L.; Starkova, J.; Janotova, I.; Sramkova, L.; Stary, J.; Zuna, J.; Stanulla, M.; Zimmermann, M.; Bourquin, J.-P.; Eckert, C.; Cario, G.; Trka, J. Less HemaSphere. 3:33, June 2019. Favorites PDF Get Content & Permissions Free
TARGETING LYSOSOMES AS A POTENTIAL THERAPEUTIC APPROACH FOR T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIAPF163 Mulet, Banus A.; Cornet-Masana, J. M.; Carbó, J. M.; More Mulet, Banus A.; Cornet-Masana, J. M.; Carbó, J. M.; Cuesta-Casanovas, L.; Guijarro, F.; Esteve, J.; Risueño, R. Less HemaSphere. 3:33-34, June 2019. Favorites PDF Get Content & Permissions Free
CD9 IS AN ADVERSE PROGNOSTIC MARKER AND PROMISING THERAPEUTIC TARGET IN HIGH-RISK PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIAPF164 Zhang, C.; Cheung, J. T. K.; Chan, K. Y. Y.; More Zhang, C.; Cheung, J. T. K.; Chan, K. Y. Y.; Wang, H.; Man, T. K. F.; Li, K.; Li, C. K.; Leung, K. T. Less HemaSphere. 3:34, June 2019. Favorites PDF Get Content & Permissions Free
THE XPO1 INHIBITOR KPT-8602 WORKS SYNERGISTIC WITH DEXAMETHASONE TO INHIBIT ACUTE LYMPHOBLASTIC LEUKEMIA CELLSPF165 Verbeke, D.; de Bock, C.; Demeyer, S.; More Verbeke, D.; de Bock, C.; Demeyer, S.; Prieto, C.; De Bie, J.; Gielen, O.; Mentens, N.; Daelemans, D.; Uyttebroeck, A.; Boeckx, N.; De Keersmaecker, K.; maertens, J.; Segers, H.; Cools, J. Less HemaSphere. 3:34-35, June 2019. Favorites PDF Get Content & Permissions Free
RASD1 INHIBITS THE PROLIFERATION OF LEUKEMIA CELLS AND CORRELATES WITH LEUKEMIA RELAPSE IN ADULTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAPF166 Lu, R.-Q.; Wu, L.-X.; Zhang, J.; More Lu, R.-Q.; Wu, L.-X.; Zhang, J.; Qin, Y.-Z.; Liu, Y.-R.; Lai, Y.-Y.; Jiang, H.; Jiang, Q.; Chang, Y.-J.; Ruan, G.-R.; Huang, X.-J. Less HemaSphere. 3:35, June 2019. Favorites PDF Get Content & Permissions Free
THE TETRASPANIN CD9 REGULATES GLUCOCORTICOID SENSITIVITY IN PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIAPF167 Li, J. M. H.; Zhang, C.; Cheung, J. T. K.; More Li, J. M. H.; Zhang, C.; Cheung, J. T. K.; Chan, K. Y. Y.; Li, K.; Li, C. K.; Leung, K. T. Less HemaSphere. 3:35-36, June 2019. Favorites PDF Get Content & Permissions Free
KINASE AND CYTOKINE RECEPTOR SIGNALING PATHWAY ACTIVATING ALTERATIONS IN UNIFORMLY TREATED B-ALLPF168 Norvilas, R.; Dirse, V.; Sema-keviciene, R.; More Norvilas, R.; Dirse, V.; Sema-keviciene, R.; Mickeviciute, O.; Vaitkeviciene, G.; Rascon, J.; Griškevicius, L. Less HemaSphere. 3:36, June 2019. Favorites PDF Get Content & Permissions Free
LONG-TERM INHIBITION OF CHK1/CHK2 KINASES MODIFY ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINE RESPONSE TO DNA DAMAGING AGENTSPF169 Luserna Di Rora', Ghelli A.; Bocconcelli, M.; Padella, A.; More Luserna Di Rora', Ghelli A.; Bocconcelli, M.; Padella, A.; Fontana, M. C.; Ferrari, A.; Imbrogno, E.; Baldazzi, C.; Testoni, N.; Simonetti, G.; Martinelli, G. Less HemaSphere. 3:36, June 2019. Favorites PDF Get Content & Permissions Free
ETV6/RUNX1 FUSION GENE ABROGATION DECREASE THE ONCOGENIC POTENCIAL OF TUMORS CELLS IN A PRECLINICAL MODEL OF ACUTE LYMPHOBLASTIC LEUKEMIAPF170 Montaño, A.; Ordóñez, J. L.; Alonso-Pérez, V.; More Montaño, A.; Ordóñez, J. L.; Alonso-Pérez, V.; MarÃn-QuÃlez, A.; Pérez-Carretero, C.; Benito, R.; GarcÃa-Tuñón, I.; Hernández-Rivas, J. M. Less HemaSphere. 3:36-37, June 2019. Favorites PDF Get Content & Permissions Free
DIFFERENTIAL EXPRESSION PATTERNS OF SPECIFIC LONG NONCODING RNAS AND COMPETING ENDOGENOUS RNA NETWORK IN ACUTE LYMPHOCYTE LEUKEMIAPF171 Wang, W.; Ma, J.; Gan, S.; More Wang, W.; Ma, J.; Gan, S.; Jiang, Z.; Sun, L.; Sun, H. Less HemaSphere. 3:37, June 2019. Favorites PDF Get Content & Permissions Free
PROSPECTIVE COMPARISON OF SANGER SEQUENCING VS NEXT GENERATION SEQUENCING FOR ROUTINE BCR-ABL1 KINASE DOMAIN MUTATION SCREENING IN PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTSPF172 Soverini, S.; Martelli, M.; Bavaro, L.; More Soverini, S.; Martelli, M.; Bavaro, L.; Papayannidis, C.; Sica, S.; Sorà , F.; Albano, F.; Galimberti, S.; Barate', C.; Rondoni, M.; Abruzzese, E.; Annunziata, M.; Russo, S.; Mannina, D.; Stulle, M.; Imovilli, A.; Curti, A.; Bonifacio, M.; Ferrero, D.; Basilico, C.; Reddiconto, G.; Mineo, G.; Laginestra, M. A.; Pileri, S. A.; Mignone, F.; Percesepe, A.; Martinelli, G.; Cavo, M. Less HemaSphere. 3:37-38, June 2019. Favorites PDF Get Content & Permissions Free
RESULTS FROM UKALL60+, A UK PHASE 2 STUDY IN ELDERLY PATIENTS WITH UNTREATED ACUTE LYMPHOBLASTIC LEUKAEMIAPF173 Morley, N.; Kirkwood, A.; Moorman, A.; More Morley, N.; Kirkwood, A.; Moorman, A.; Clifton-Hadley, L.; Moreira, L.; Rowntree, C.; Wrench, B.; Marwood, E.; Patrick, P.; Snowden, J. A.; Marks, D. I.; Fielding, A. K. Less HemaSphere. 3:38-39, June 2019. Favorites PDF Get Content & Permissions Free
GERIATRIC ASSESSMENT-BASED TREATMENT OF ELDERLY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS. RESULTS OF THE GIMEMA LAL1104 PROTOCOLPF174 Chiaretti, S.; Cesini, L.; Di Raimondo, F.; More Chiaretti, S.; Cesini, L.; Di Raimondo, F.; Angelucci, E.; Luppi, M.; Bonifacio, M.; Cascavilla, N.; Fozza, C.; La Sala, E.; Soddu, S.; Fazi, P.; Vitale, A.; Foà , R.; Ferrara, F. Less HemaSphere. 3:39, June 2019. Favorites PDF Get Content & Permissions Free
MULTICENTRE STANDARDIZATION OF MINIMAL RESIDUAL DISEASE DETECTION AND QUANTITATION USING THE EUROCLONALITY-NGS ASSAYPF175 Svaton, M.; Fronkova, E.; Kotrova, M.; More Svaton, M.; Fronkova, E.; Kotrova, M.; Reigl, T.; Caye, A.; de Bie, M.; Genuardi, E.; Jelinkova, H.; Lim, E. H.; Nishijima, D.; Pal, K.; Salemi, D.; Sarasquete, M. E.; Songia, S.; Tosi, M.; Villarese, P.; Wakeman, S.; Cave, H.; Cazzaniga, G.; Ferrero, S.; Sanz, Garcia R.; Hancock, J.; Macintyre, E.; Plevova, K.; Sanada, M.; Santoro, A.; Spinelli, O.; van der Velden, V. H.; Yeoh, A. E. J.; Langerak, A. W.; Darzentas, N.; Brüggemann, M.; Trka, J. Less HemaSphere. 3:39-40, June 2019. Favorites PDF Get Content & Permissions Free
MONOCYTIC SWITCH AND DISCREPANCY BETWEEN FLOW CYTOMETRIC AND MOLECULAR MINIMAL RESIDUAL DISEASE ARE FREQUENT IN DUX4 REARRANGED AND PAX5-P80R MUTATED B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIAPF176 Novakova, M.; Vakrmanova, B.; Slamova, L.; More Novakova, M.; Vakrmanova, B.; Slamova, L.; Musilova, A.; Bruggemann, M.; Ritgen, M.; Kolenovska, A.; Svec, P.; Fronkova, E.; Kalina, T.; Trka, J.; Stary, J.; Vaskova, M.; Winkowska, L.; Zaliova, M.; Fiser, K.; Hrusak, O.; Mejstrikova, E. Less HemaSphere. 3:40-41, June 2019. Favorites PDF Get Content & Permissions Free
NATION-WIDE PROSPECTIVE, REAL-TIME MONITORING OF PEGYLATED E.COLI AND ERWINIA ASPARAGINASE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA IN BELGIUMPF177 Mondelaers, V.; Lammens, T.; Dedeken, L.; More Mondelaers, V.; Lammens, T.; Dedeken, L.; Uyttebroeck, A.; Brichard, B.; van der Werff ten Bosch, J.; Norga, K.; Francotte, N.; Piette, C.; Benoit, Y.; De Moerloose, B. Less HemaSphere. 3:41, June 2019. Favorites PDF Get Content & Permissions Free
DEFINITION OF REPRESENTATIVE BONE MARROW SAMPLE BASED ON PARALLEL EVALUATION OF PERIPHERAL BLOOD DURING THE THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIAPF178 Vakrmanova, B.; Novakova, M.; Stary, J.; More Vakrmanova, B.; Novakova, M.; Stary, J.; Hrusak, O.; Mejstrikova, E. Less HemaSphere. 3:41, June 2019. Favorites PDF Get Content & Permissions Free
DIFFERENT IMPACT OF BCR BREAKPOINT ON THE OUTCOME OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FROM DIFFERENT GRAFT SOURCE FOR PH+ALL IN THE ERA OF TKIPF179 Nishiwaki, S.; Mizuta, S.; Ohashi, K.; More Nishiwaki, S.; Mizuta, S.; Ohashi, K.; Fukuda, T.; Uchida, N.; Kanamori, H.; Onizuka, M.; Ozawa, Y.; Tanaka, J.; Ichinohe, T.; Atsuta, Y.; Kako, S. Less HemaSphere. 3:42, June 2019. Favorites PDF Get Content & Permissions Free
THE SIGNIFICANCE OF MONOSOMAL KARYOTYPE IN PHILADELPHIA CHROMOSOME NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIAPF180 Li, Z.; Jiang, Q.; Lai, Y.; More Li, Z.; Jiang, Q.; Lai, Y.; Zhang, X.; Xu, L.; Liu, K.; Wang, Y.; Jiang, H.; Huang, X. Less HemaSphere. 3:42, June 2019. Favorites PDF Get Content & Permissions Free
PEDIATRIC-INSPIRED REGIMEN PLUS HDACI CHIDAMIDE YIELDED PROMISING RESPONSE IN PH-LIKE AND ETP ACUTE LYMPHOBLASTIC LEUKEMIAPF181 Zhou, H.; Gao, Y.; Wang, Q.; More Zhou, H.; Gao, Y.; Wang, Q.; Cao, R.; Yin, C.; Zhou, X.; Li, Q.; He, X.; Huang, K.; Liu, N.; Lin, D.; Liu, X.; Liu, Q. Less HemaSphere. 3:42-43, June 2019. Favorites PDF Get Content & Permissions Free
CLINICOBIOLOGIC CHARACTERISTICS AND OUTCOME OF ELDERLY FRAIL PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA INCLUDED IN A SPECIFIC PROTOCOL (ALL-07FRAIL)PF182 Ribera, J. M.; GarcÃa-Calduch, O.; Gil, C.; More Ribera, J. M.; GarcÃa-Calduch, O.; Gil, C.; González-Campos, J.; Moreno, M. J.; Barba, P.; Amigo, M. L.; MartÃnez-Carballeira, D.; Alonso, N.; Bergua, J. M.; Mercadal, S.; Cladera, A.; Vall-Llovera, F.; GarcÃa-Guiñón, A.; López, A.; Lavilla, E.; Sierra, M.; Hernández-Rivas, J. M. Less HemaSphere. 3:43, June 2019. Favorites PDF Get Content & Permissions Free
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN CHILDREN WITH HEMATOLOGHIC AND ONCOLOGIC DISEASES: MULTICENTER EXPERIENCEPF183 Bilir, Arman O.; Dikme, G.; Malbora, B.; More Bilir, Arman O.; Dikme, G.; Malbora, B.; Evim, M. S.; OnderSivis, Z.; Tufekci, O.; Bahadir, A.; Karaman, S.; Vural, S.; Bayhan, T.; Celkan, T.; Ozbek, N. Y. Less HemaSphere. 3:43-44, June 2019. Favorites PDF Get Content & Permissions Free
EFFICACY OF CONSOLIDATION CHEMOTHERAPY FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA WHO ACHIEVED COMPLETE REMISSION BY FIRST COURSE OF REMISSION INDUCTION THERAPYPF184 Shigematsu, A.; Ota, S.; Kobayashi, R.; More Shigematsu, A.; Ota, S.; Kobayashi, R.; Kondo, T.; Endo, T.; Tsutsumi, Y.; Kobayashi, H.; Kakinoki, Y.; Yamamoto, S.; Konuma, Y.; Miyagishima, T.; Igarashi, T.; Oda, T.; Sakai, H.; Ishihara, T.; Yoshida, M.; Nagashima, T.; Sato, K.; Kanisawa, Y.; Haseyama, T.; Hirayama, Y.; Kurosawa, M. Less HemaSphere. 3:44, June 2019. Favorites PDF Get Content & Permissions Free
WT1 OVEREXPRESSION PREDICTED GOOD OUTCOMES IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPYPF185 Wang, S.; Wang, C.; Li, T.; More Wang, S.; Wang, C.; Li, T.; Wang, W.; Hao, Q.; Xie, X.; Wan, D.; Jiang, Z.; Liu, Y. Less HemaSphere. 3:44-45, June 2019. Favorites PDF Get Content & Permissions Free
INTENSIVE CARE OF THE LIFE -THREATING COMPLICATION DE NOVO ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS (PTS)PF186 Bazhenov, A.; Galstyan, G.; Parovichnikova, E.; More Bazhenov, A.; Galstyan, G.; Parovichnikova, E.; Troitskaya, V. Less HemaSphere. 3:45, June 2019. Favorites PDF Get Content & Permissions Free
LEUKEMIA AND DEPLETED URANIUM IN KOSOVOPF187 Latifi-Pupovci, H.; Selmonaj, M.; Ahmetaj-Shala, B.; More Latifi-Pupovci, H.; Selmonaj, M.; Ahmetaj-Shala, B.; Dushi, M.; Grajqevci, V. Less HemaSphere. 3:45-46, June 2019. Favorites PDF Get Content & Permissions Free
NGS COMBINED WITH ASO REAL-TIME PCR BASED MRD DETECTION ASSAY FOR PEDIATRIC ALL PATIENTSPF188 Nicolaou, K.; Chi, J.; Koumas, L.; More Nicolaou, K.; Chi, J.; Koumas, L.; Loizou, L.; Karaoli, E.; Papachristodoulou, E.; Loizos, A.; Costeas, P. Less HemaSphere. 3:46, June 2019. Favorites PDF Get Content & Permissions Free
APPROPRIATE INTERVAL OF MONITORING FOR DETECTION OF MOLECULAR RELAPSE AFTER STOP OF TKI IN PH+ALL IN PH+ ALL CALCULATING BY MRD KINETICSPF189 Miyamura, K.; Morishita, T.; Goto, T.; More Miyamura, K.; Morishita, T.; Goto, T.; Nishiwaki, S.; Ozawa, Y. Less HemaSphere. 3:46-47, June 2019. Favorites PDF Get Content & Permissions Free
PLASMA LEVELS AND OUTCOMES OF PROPHYLACTIC POST-TRANSPLANT PONATINIB ADMINISTRATION IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL)PF190 Nanno, S.; Okamura, H.; Nakamae, M.; More Nanno, S.; Okamura, H.; Nakamae, M.; Hirose, A.; Matsumoto, K.; Morita, K.; Nakashima, Y.; Koh, H.; Nakane, T.; Hino, M.; Nakamae, H. Less HemaSphere. 3:47, June 2019. Favorites PDF Get Content & Permissions Free
RECLASSIFICATION OF BIPHENOTYPIC ACUTE LEUKEMIA INTO MIXED-PHENOTYPE ACUTE LEUKEMIA ACCORDING TO WHO CRITERIA REFINES PATIENT CHARACTERIZATION AND PROGNOSIS; DISEASE MARKERS AND IMPACT ON OUTCOMEPF191 Douka, V.; Kotta, K.; Chatziioannidis, A.; More Douka, V.; Kotta, K.; Chatziioannidis, A.; Iskas, M.; Athanasiadou, A.; Papathanasiou, M.; Lalayanni, C.; Syrigou, A.; Tachynopoulou, V.; Avramidou, R.; Vadikolia, C.; Tsompanakou, A.; Anagnostopoulos, A. Less HemaSphere. 3:47-48, June 2019. Favorites PDF Get Content & Permissions Free
CLINICAL PROFILE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN HAEMATOLOGY PATIENTS AT A TERTIARY CARE CENTREPF192 Gupta, G.; Seth, T.; Mahapatra, M.; More Gupta, G.; Seth, T.; Mahapatra, M.; Aggarwal, M.; Dhawan, R. Less HemaSphere. 3:48, June 2019. Favorites PDF Get Content & Permissions Free
NO BLASTS AT DAY 8 IS BETTER THAN MORE IN CORTICO-SENSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDRENPF193 Frikha, I.; Turki, I.; Medhaffer, M.; More Frikha, I.; Turki, I.; Medhaffer, M.; Hdijji, S.; Ben Amor, I.; Charfi, M.; Kassar, O.; Ghorbel, M.; Kallel, F.; Elloumi, M. Less HemaSphere. 3:49, June 2019. Favorites PDF Get Content & Permissions Free
EVALUATION OF TELOMERE LENGTH AND TELOMERASE ACTIVITY AS PROGNOSTIC MARKERS IN A PEDIATRIC PATIENT COHORT WITH ACUTE LYMPHOBLASTIC LEUKEMIAPF194 Haubitz, M.; Karow, A.; Helsen, I.; More Haubitz, M.; Karow, A.; Helsen, I.; Steiner, D.; Ammann, R. A.; Kartal-Kaess, M.; Rössler, J. K.; Leibundgut, Oppliger E.; Baerlocher, G. M. Less HemaSphere. 3:49, June 2019. Favorites PDF Get Content & Permissions Free
THE IMPACT OF COMORBIDITY ON SURVIVAL OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIAPF195 Demichelis, R.; Chouciño, P.; GarcÃa, A.; More Demichelis, R.; Chouciño, P.; GarcÃa, A.; Ramos, R.; Sánchez, J. M.; Bourlon, C. Less HemaSphere. 3:49-50, June 2019. Favorites PDF Get Content & Permissions Free
IDENTICAL TWINS DO NOT DISPLAY INCREASED CONCORDANCE FOR CLONAL HEMATOPOIESISPF196 Fabre, M.; McKerrell, T.; Zwiebel, M.; More Fabre, M.; McKerrell, T.; Zwiebel, M.; Vijayabaskar, M.; Rad, R.; Deloukas, P.; Small, K.; Steves, C. J.; Vassiliou, G. Less HemaSphere. 3:50, June 2019. Favorites PDF Get Content & Permissions Free
A NEW CLASSIFICATION OF ACUTE MYELOID LEUKEMIA BASED ON INTEGRATED GENOMICS AND METABOLOMICSPF197 Simonetti, G.; Padella, A.; Mengucci, C.; More Simonetti, G.; Padella, A.; Mengucci, C.; Fonzi, E.; Picone, G.; Pazzaglia, M.; Perricone, M.; Fontana, M.; Bruno, S.; Bochicchio, M. T.; Franchini, E.; Nanni, J.; Marconi, G.; do Valle, I. F.; De Tommaso, R.; Ferrari, A.; Ghetti, M.; Napolitano, R.; Papayannidis, C.; Luseran di Rorà , Ghelli A.; Cerchione, C.; Ottaviani, E.; Castellani, G.; Remondini, D.; Capozzi, F.; Martinelli, G. Less HemaSphere. 3:51, June 2019. Favorites PDF Get Content & Permissions Free
THE IMPACT OF PPM1D MUTATIONS ON THE DNA DAMAGE RESPONSE AND CLONAL EVOLUTIONPF198 Hsu, J.; Dayaram, T.; Tovy, A.; More Hsu, J.; Dayaram, T.; Tovy, A.; Donehower, L.; Goodell, M. Less HemaSphere. 3:51-52, June 2019. Favorites PDF Get Content & Permissions Free
TARGETING BRD4 IN MLL-PTD AMLPF199 Pepe, F.; McNeil, B.; Ozer, H. G.; More Pepe, F.; McNeil, B.; Ozer, H. G.; Karunasiri, M.; Bill, M.; Garzon, R.; Dorrance, A. Less HemaSphere. 3:52, June 2019. Favorites PDF Get Content & Permissions Free
CARBENOXOLONE REVERSES MICROENVIRONMENT-INDUCED CHEMORESISTANCE OF ACUTE MYELOID LEUKEMIAPF200 Kouzi, F.; Zibara, K.; Picou, F.; More Kouzi, F.; Zibara, K.; Picou, F.; Bourgeais, J.; Gallay, N.; Dakik, H.; Roux, B.; Hamard, S.; Le Nail, L.-R.; Hleihel, R.; Foucault, A.; Ravalet, N.; Rouleux-Bonnin, F.; Gouilleux, F.; Mazurier, F.; Gyan, E.; Domenech, J.; El-Sabban, M.; Herault, O. Less HemaSphere. 3:52-53, June 2019. Favorites PDF Get Content & Permissions Free
